Neuralink, spearheaded by entrepreneur Elon Musk, has achieved a groundbreaking milestone by successfully implanting its wireless brain chip in a human subject. Musk reported positive initial outcomes, with the detection of promising neuron spikes and the patient's favorable recovery progress.
The company's overarching objective is to forge a direct link between the human brain and computers, aiming to address intricate neurological conditions. Securing permission from the U.S. Food and Drug Administration (FDA) in May marked a pivotal moment for Neuralink, overcoming previous regulatory hurdles and paving the way for a six-year study.
During this study, a specialized robot is utilized to surgically insert 64 ultra-thin threads, finer than human hair, into a specific brain region controlling "movement intention." These threads facilitate the wireless recording and transmission of brain signals to an application, decoding the individual's intended movements.
A notable aspect of the experimental implant is its wireless functionality, powered by a rechargeable battery. Elon Musk, in a post on his social media platform X (formerly Twitter), disclosed that Neuralink's inaugural product will be named "Telepathy," emphasizing the company's pursuit of unlocking new frontiers in human-computer interfacing.